Similar articles

• [Antifibrinolytic agents and their therapeutic use].

  Fischer M. Fischer M. Folia Haematol Int Mag Klin Morphol Blutforsch. 1969;92(1):64-77. Folia Haematol Int Mag Klin Morphol Blutforsch. 1969. PMID: 4189375 German. No abstract available.
• Anticoagulant effects of Trasylol: in vitro and in vivo studies.

  Amris CJ, Hilden M. Amris CJ, et al. Ann N Y Acad Sci. 1968 Jun 28;146(2):612-24. doi: 10.1111/j.1749-6632.1968.tb20319.x. Ann N Y Acad Sci. 1968. PMID: 5306290 No abstract available.
• [Diagnosis and treatment of intravascular coagulation processes].

  Moriau M, Masure R. Moriau M, et al. Nouv Rev Fr Hematol. 1968 Jan-Feb;8(1):5-19. Nouv Rev Fr Hematol. 1968. PMID: 4232151 French. No abstract available.
• [Different forms of utilization coagulopathy and their treatment].

  Herschlein HJ, Steichele DF. Herschlein HJ, et al. Med Welt. 1969 Nov 1;44:2389-98. Med Welt. 1969. PMID: 4915798 Review. German. No abstract available.
• Indications for antifibrinolytic therapy.

  Prentice CR. Prentice CR. Thromb Diath Haemorrh. 1975 Dec 15;34(3):634-43. Thromb Diath Haemorrh. 1975. PMID: 1108280 Review. No abstract available.